📰 Medication Control News
Page 11 - Medication Control News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Medication Control. Real-time updates on events, politics, business and more.
March 7, 2023
Covered Persons and Horses who are not in compliance with HISA’s Racetrack Safety and Registration rules, which went into effect on July 1, 2022, will be at risk of being unable to race until they comply with the rules.
March 3, 2023
The CHRB is proud of our work and record in safety and animal welfare, and therefore we want to have a role in shaping policy going forward,
February 28, 2023
HISA's Anti-Doping And Medication Control Program To Include Efficient Results Management, Adjudication Processes
February 27, 2023
Horseracing Integrity and Safety Authority CEO Lisa Lazarus said the organization is on a one-month countdown to an anticipated March 27 launch of its Anti-Doping and Medication Control program.
February 17, 2023
These standardized testing protocols are designed to promote the integrity of Thoroughbred racing and the safety of the horse while modernizing the sample collection process at Thoroughbred tracks nationwide.
February 12, 2023
The Maryland Thoroughbred Horsemen’s Association and Maryland Jockey Club will host an open forum for horsemen with Dr. Mary Scollay, Chief of Science for the Horseracing Integrity & Welfare Unit, to discuss the Horseracing Integrity and Safety Authority’s Anti-Doping and Medication Control Program.
February 10, 2023
The investigations unit will be led by Shawn Loehr and Naushaun “Shaun” Richards, who will be guided by their decades experiences
February 9, 2023
Dr. Scott Palmer, equine medical director for New York, discusses the progress made over the last decade in reducing fatalities in horse racing.
January 30, 2023
HIWU is honored to have been tasked with the responsibility of administering U.S. Thoroughbred racing’s first national, uniform ADMC Program, and we stand ready to begin enforcement this spring,” said Ben Mosier, executive director of HIWU
January 27, 2023
The FTC now has 60 days to approve or deny HISA's proposed medication rules, meaning HISA expects to implement the rules on March 27